A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients with cancer or Leptomeningeal Metastases.
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 21 Mar 2017
At a glance
- Drugs Pemetrexed (Primary) ; Pemetrexed (Primary)
- Indications Cancer metastases; Haematological malignancies; Lymphoma; Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacokinetics; Therapeutic Use
- 15 Mar 2017 Planned End Date changed from 1 Mar 2016 to 1 Mar 2020.
- 15 Mar 2017 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2018.
- 07 Jul 2014 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.